Myriad Genetics, Inc. (MYGN)


Stock Price Forecast

March 15, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Myriad Genetics, Inc. chart...

About the Company

myriad genetics inc., is a leading personalized medicine company dedicated to being a trusted advisor transforming patient lives worldwide with pioneering molecular diagnostics. myriad discovers and commercializes molecular diagnostic tests that: determine the risk of developing disease, accurately diagnose disease, assess the risk of disease progression, and guide treatment decisions across six major medical specialties where molecular diagnostics can significantly improve patient care and lower healthcare costs. myriad is focused on three strategic imperatives: maintaining leadership in an expanding hereditary cancer market, diversifying its product portfolio through the introduction of new products and increasing the revenue contribution from international markets. for more information on how myriad is making a difference, please visit the company's website: www.myriad.com.

CEO

R. Bryan Riggsbee

Exchange

NASDAQ

Website

http://www.myriad.com/

$190M

Total Revenue

3K

Employees

$2B

Market Capitalization

-6.20

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $MYGN News

Myriad Genetics (MYGN) Q4 Earnings Top Estimate, Margins Down

19d ago, source: Zacks.com on MSN

Myriad Genetics, Inc. MYGN reported an adjusted earnings per share (EPS) of 4 cents per share in the fourth quarter of 2023 ...

Myriad Genetics: Hold Rating Amidst Growth and Market Uncertainty

18d ago, source:

Myriad Genetics (MYGN – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst on February 27. Analyst ...

University of Utah names 2024 honorary doctorate degree recipients

on MSN ago, source:

Humanitarian Pamela J. Atkinson, philanthropist Catherine Roper Meldrum and renowned computer science researcher Steven G.

CareDx Appoints Bryan Riggsbee to Its Board of Directors

7d ago, source:

The Transplant Company™ — a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant ...

Cincinnati Regional Chamber selects 55 young leaders for Cincy Next class 11

11h ago, source:

The Cincinnati Regional Chamber has named 55 emerging leaders for its 11th class of Cincy Next, a leadership development ...

Citi starts Catalyst at buy, cites rare disease drug portfolio

on MSN ago, source:

Citi started coverage of Catalyst Pharmaceuticals (CPRX) with a buy rating, citing the company’s rare disease drug portfolio ...

FDA approves Orchard’s gene therapy for children with rare genetic disease

8h ago, source:

This decision marks the first FDA-approved treatment for children with a rare genetic disease called metachromatic ...

Genetic Testing Market Size, Share And Growth Report 2024-2032

22h ago, source: Mena FN

What is the demand for genetic testing? The global genetic testing market size reached US$ 17.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 43.1 Billion by 2032, ...

Piper Sandler Reaffirms Their Buy Rating on Cytek Biosciences (CTKB)

12d ago, source:

In a report released today, David Westenberg from Piper Sandler maintained a Buy rating on Cytek Biosciences (CTKB – Research Report), ...

Catalyst announces US launch of Duchenne drug Agamree

on MSN ago, source:

Catalyst Pharmaceuticals (CPRX) said it has commercially launched Agamree in the U.S. for the treatment Duchenne muscular ...

An AI-Designed Drug Is Moving Toward Approval at an Impressive Clip

9h ago, source: Singularity Hub

The team behind the first AI-designed drug to hit Phase II clinical trials have now published a paper on how they developed ...

Global Consumer Genomics Market Size To Worth USD 7.48 Billion By 2033 | CAGR of 18.85%

6d ago, source:

The Global Consumer Genomics Market Size was Valued at USD 1.33 Billion in 2023 and the Worldwide Consumer Genomics Market Size is Expected to Reach USD 7.48 Billion by 2033, according to a research ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...